Organogenesis Holdings Inc (ORGO) Shares on the Rise: Short-term Analysis

A share price of Organogenesis Holdings Inc [ORGO] is currently trading at $3.33, up 3.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ORGO shares have gain 6.39% over the last week, with a monthly amount drifted -2.06%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Organogenesis Holdings Inc [NASDAQ: ORGO] stock has seen the most recent analyst activity on June 28, 2024, when Lake Street initiated its Buy rating and assigned the stock a price target of $5. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on February 07, 2024, and set its price target to $5. On June 15, 2023, Morgan Stanley initiated with a Equal-Weight rating and assigned a price target of $5 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $10 on May 24, 2023. BTIG Research downgraded its rating to a Neutral. Oppenheimer downgraded its rating to Perform for this stock on August 10, 2022. In a note dated January 10, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $9 on this stock.

Organogenesis Holdings Inc experienced fluctuations in its stock price throughout the past year between $2.16 and $4.57. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Organogenesis Holdings Inc [NASDAQ: ORGO] shares were valued at $3.33 at the most recent close of the market. An investor can expect a potential return of 50.15% based on the average ORGO price forecast.

Analyzing the ORGO fundamentals

Trailing Twelve Months sales for Organogenesis Holdings Inc [NASDAQ:ORGO] were 455.04M which represents 6.12% growth. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.39.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.24 points at the first support level, and at 3.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.38, and for the 2nd resistance point, it is at 3.42.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Organogenesis Holdings Inc [NASDAQ:ORGO] is 3.09. Also, the Quick Ratio is 2.74, while the Cash Ratio stands at 1.22. Considering the valuation of this stock, the price to sales ratio is 0.92, the price to book ratio is 1.58.

Transactions by insiders

Recent insider trading involved Gillheeney Gary S., President and CEO, that happened on Dec 13 ’24 when 55615.0 shares were sold. President and CEO, Gillheeney Gary S. completed a deal on Dec 16 ’24 to sell 5585.0 shares. Meanwhile, President and CEO Gillheeney Gary S. sold 0.16 million shares on Dec 11 ’24.

Related Posts